HIF-2α Interaction with Ataxin-10 Enhances HIF-2α Binding to Its Target Gene Promoters

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Signaling

Background:

• Hypoxia-inducible factors (HIFs) regulate cellular adaptation to low oxygen.
• HIF-2α, a less-studied isoform, is linked to increased tumor malignancy.
• Ataxin-10 is an intracellular protein involved in cell survival and differentiation.

Purpose of the Study:

• To investigate the interaction between HIF-2α and Ataxin-10.
• To elucidate the mechanism and effects of this interaction in cervical cancer and glioma cells.
• To identify potential therapeutic targets for cancer treatment.

Main Methods:

• LC-MS/MS proteomic analysis
• Immunoprecipitation and immunoblotting
• Luciferase assays and quantitative RT-PCR
• Immunofluorescence microscopy, subcellular fractionation, siRNA, in vitro binding assays, and ChIP

Main Results:

• Ataxin-10 specifically interacts with HIF-2α at its carboxyterminal activation domain.
• This interaction enhances HIF-2α binding to chromatin in Hypoxia Response Elements.
• Transcriptional activity of HIF-2 target genes (SERPINE1, CITED-2, SOD-2) is increased under hypoxia.

Conclusions:

• A novel mechanism for fine-tuning HIF-2 transcriptional activity is identified.
• The HIF-2α-Ataxin-10 interaction represents a potential therapeutic strategy for cancers.
• Further research may lead to new treatments for tumors associated with HIF-2α expression.